Microstructural properties of bone in rat vertebra after long-term clodronate treatment

Journal of Bone and Mineral Metabolism

Volumn 20, Issue 4, 2002, Pages 223-227

  Koivukangas, Antti ^a   Tuukkanen, Juha ^a   Lehenkari, Petri ^a   Peura, Raija ^a   Hannuniemi, Ritva ^b   Kippo, Katriina ^b   Jämsä, Timo ^a   Jalovaara, Pekka ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Biomedical Research Center   (Finland)

Author keywords

Bisphosphonate; Clodronate; Long term; Rat

Indexed keywords

CALCIUM; CLODRONIC ACID; MAGNESIUM; PHOSPHORUS; SODIUM CHLORIDE; ANALGESIC AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE STRUCTURE; CHEMICAL COMPOSITION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; IMAGING; LONG TERM CARE; LUMBAR VERTEBRA; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SPECTROMETRY; STATISTICAL SIGNIFICANCE; TRABECULAR BONE; VERTEBRA BODY; ANIMAL; DOSE RESPONSE; DRUG EFFECT; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANALGESICS, NON-NARCOTIC; ANIMALS; BONE DENSITY; CLODRONIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUMBAR VERTEBRAE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0036044878     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007740200032     Document Type: Article

References (22)

1. Fleisch H (2000) Bisphosphonates in Bone Disease. From Laboratory to the Patient. Academic Press, London
2. Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42:919-944
3. Russell RG, Rogers MJ (1999) Bisphosphonates: from the laboratory to the clinic and back again. Bone 25:97-106
4. Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80-100
5. Adami S, Zamberlan N (1996) Adverse effects of bisphosphonates. A comparative review. Drug Saf 14:158-170
6. Flora L, Hassing GS, Cloyd GG, Bevan JA, Parfitt AM, Villanueva AR (1981) The long-term skeletal effects of EHDP in dogs. Metab Bone Dis Relat Res 3:289-300
7. Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF (1993) Mineralisation defects with pamidronate therapy for Paget's disease. Lancet 342:1459-1460
8. Guy JA, Shea M, Peter CP, Morrissey R, Hayes WC (1993) Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties. Calcif Tissue Int 53:283-288
9. Geusens P, Nijs J, Van der Perre G, Van Audekercke R, Lowet G, Goovaerts S, Barbier A, Lacheretz F, Remandet B, Jiang Y (1992) Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys. J Bone Miner Res 7:599-609
10. Grynpas MD, Kasra M, Dumitriu M, Nespeca R, Very JM, Mertz BP (1994) Recovery from pamidronate (APD): a 2-year study in the dog. Calcif Tissue Int 55:288-294
11. Balena R, Toolan BC, Shea M, Markatos A, Myers ER, Lee SC, Opas EE, Seedor JG, Klein H, Frankenfield D (1993) The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J Clin Invest 92:2577-2586
12. Binkley N, Kimmel D, Bruner J, Haffa A, Davidowitz B, Meng C, Schaffer V, Green J (1998) Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys. J Bone Miner Res 13:1775-1782
13. Lepola VT, Hannuniemi R, Kippo K, Lauren L, Jalovaara P, Vaananen HK (1996) Long-term effects of clodronate on growing rat bone. Bone 18:191-196
14. Koivukangas A, Tuukkanen J, Hannuniemi R, Jamsa T, Kippo K, Jalovaara P (2001) Effects of long-term administration of clodronate on growing rat bone. Calcif Tissue Int 69:350-355
15. Wink CS (1986) A scanning electron-microscopic study of femoral bone surfaces from castrated rats treated with dichloromethylene biphosphonate. Acta Anat (Basel) 126:57-62
16. Mosekilde L, Danielsen CC, Gasser J (1994) The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents (estrogen and calcitonin), human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinology 134:2126-2134
17. Rohanizadeh R, LeGeros RZ, Bohic S, Pilet P, Barbier A, Daculsi G (2000) Ultrastructural properties of bone mineral of control and tiludronate-treated osteoporotic rats. Calcif Tissue Int 67:330-336
18. Bloebaum RD, Skedros JG, Vajda EG, Bachus KN, Constantz BR (1997) Determining mineral content variations in bone using backscattered electron imaging. Bone 20:485-490
19. Eriksen EF, Axelrod DW, Melsen F (1994) Bone Histomorphometry. Raven Press, New York
20. Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR (1986) Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc Pt 4:1537-1554
21. Boyde A, Jones SJ (1996) Scanning electron microscopy of bone: instrument, specimen, and issues. Microsc Res Tech 33:92-120
22. Marks SC, Cielinski MJ, Sundquist KT (1996) Bone surface morphology reflects local skeletal metabolism. Microsc Res Tech 33:121-127